The Guardian Business EN

US agency did not perform safety checks of more than 100 food ingredients, analysis finds

Review of FDA records by the Environmental Working Group reveals firms are exploiting rule to send new chemicals in food systemMore than 100 substances widely used in common US foods, supplements and beverages underwent no health and safety review by the US Food and Drug Administration, a new analysis of federal records finds.The review of FDA records by the Environmental Working Group (EWG) non-profit reveals that diverse products across the food pyramid, such as Capri Sun drinks, Kettle and Fire organic broth, Acme smoked fish, and Quaker Oats snack bars, use a range of substances that have not undergone review by regulators. Continue reading...

Mar 07, 2026 &03000707202631; 13:00 UTC www.theguardian.com Trending 3/5

Read original on www.theguardian.com ↗

↘

Negative for markets

Sentiment score: -65/100

High impact Medium-term (weeks)

WHAT THIS MEANS

FDA failed to conduct safety reviews on over 100 food ingredients used in popular US consumer products, creating regulatory risk for food manufacturers and potential liability exposure. This oversight could trigger increased regulatory scrutiny, product recalls, and litigation against affected companies.

AI CONFIDENCE

75% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

PEP

PEPStock

Expected to decline

Quaker Oats (PepsiCo subsidiary) products implicated in safety review gap

↓

KHC

KHCStock

Expected to decline

Kraft Heinz portfolio companies potentially affected by unreviewed ingredients

↓

MDLZ

MDLZStock

Expected to decline

Mondelez and similar food manufacturers face regulatory and reputational risk

⇅

S&P 500

^GSPCIndex

High volatility expected

Consumer staples sector volatility due to regulatory uncertainty

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Short consumer staples stocks (PEP, KHC, MDLZ) on regulatory risk; consider long positions in food safety testing companies and legal services firms. Monitor FDA response and potential legislative action over next 2-4 weeks.

KEY SIGNALS

Regulatory gap in FDA oversight creates compliance riskPotential for product recalls and litigationReputational damage to major food brandsIncreased regulatory scrutiny expectedSupply chain disruption risk

SECTORS INVOLVED

Consumer StaplesFood & BeverageHealthcare/PharmaceuticalsRegulatory/Compliance

Analysis generated on Mar 09, 2026 at 17:48 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by The Guardian Business. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

US agency did not perform safety checks of more than 100 food ingredients, analysis finds

RELATED INTELLIGENCE